These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 9915874

  • 1. Oral triacylglycerols regulate plasma glucagon-like peptide-1(7-36) and insulin levels in normal and especially in obese rats.
    Iritani N, Sugimoto T, Fukuda H, Komiya M, Ikeda H.
    J Nutr; 1999 Jan; 129(1):46-50. PubMed ID: 9915874
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.
    Ranganath L, Norris F, Morgan L, Wright J, Marks V.
    Clin Sci (Lond); 1999 Apr; 96(4):335-42. PubMed ID: 10087239
    [Abstract] [Full Text] [Related]

  • 3. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA, Siemsglüss J, Orskov C, Holst JJ.
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [Abstract] [Full Text] [Related]

  • 4. Effects of an olive oil-enriched diet on plasma GLP-1 concentration and intestinal content, plasma insulin concentration, and glucose tolerance in normal rats.
    Prieto PG, Cancelas J, Villanueva-Peñacarrillo ML, Valverde I, Malaisse WJ.
    Endocrine; 2005 Mar; 26(2):107-15. PubMed ID: 15888922
    [Abstract] [Full Text] [Related]

  • 5. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
    Rocca AS, LaGreca J, Kalitsky J, Brubaker PL.
    Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.
    Thomsen C, Rasmussen O, Lousen T, Holst JJ, Fenselau S, Schrezenmeir J, Hermansen K.
    Am J Clin Nutr; 1999 Jun; 69(6):1135-43. PubMed ID: 10357731
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
    Thomsen C, Storm H, Holst JJ, Hermansen K.
    Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850
    [Abstract] [Full Text] [Related]

  • 8. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [Abstract] [Full Text] [Related]

  • 9. Elevated glucagon-like peptide-1-(7-36)-amide, but not glucose, associated with hyperinsulinemic compensation for fat feeding.
    van Citters GW, Kabir M, Kim SP, Mittelman SD, Dea MK, Brubaker PL, Bergman RN.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5191-8. PubMed ID: 12414891
    [Abstract] [Full Text] [Related]

  • 10. Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats.
    Hendrick GK, Gjinovci A, Baxter LA, Mojsov S, Wollheim CB, Habener JF, Weir GC.
    Metabolism; 1993 Jan; 42(1):1-6. PubMed ID: 8446036
    [Abstract] [Full Text] [Related]

  • 11. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats.
    Kok NN, Morgan LM, Williams CM, Roberfroid MB, Thissen JP, Delzenne NM.
    J Nutr; 1998 Jul; 128(7):1099-103. PubMed ID: 9649591
    [Abstract] [Full Text] [Related]

  • 12. Effects of glucagon-like peptide-I on glucose turnover in rats.
    Van Dijk G, Lindskog S, Holst JJ, Steffens AB, Ahrén B.
    Am J Physiol; 1996 Jun; 270(6 Pt 1):E1015-21. PubMed ID: 8764187
    [Abstract] [Full Text] [Related]

  • 13. Postprandial glucagon-like peptide-1 secretion is increased during the progression of glucose intolerance and obesity in high-fat/high-sucrose diet-fed rats.
    Nakajima S, Hira T, Hara H.
    Br J Nutr; 2015 May 14; 113(9):1477-88. PubMed ID: 25827219
    [Abstract] [Full Text] [Related]

  • 14. Involvement of endogenous glucagon-like peptide-1(7-36) amide on glycaemia-lowering effect of oligofructose in streptozotocin-treated rats.
    Cani PD, Daubioul CA, Reusens B, Remacle C, Catillon G, Delzenne NM.
    J Endocrinol; 2005 Jun 14; 185(3):457-65. PubMed ID: 15930172
    [Abstract] [Full Text] [Related]

  • 15. Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes.
    Brynes AE, Edwards CM, Jadhav A, Ghatei MA, Bloom SR, Frost GS.
    Am J Clin Nutr; 2000 Nov 14; 72(5):1111-8. PubMed ID: 11063437
    [Abstract] [Full Text] [Related]

  • 16. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
    Valverde I, Puente J, Martín-Duce A, Molina L, Lozano O, Sancho V, Malaisse WJ, Villanueva-Peñacarrillo ML.
    Obes Surg; 2005 Mar 14; 15(3):387-97. PubMed ID: 15826475
    [Abstract] [Full Text] [Related]

  • 17. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
    Galloway SD, Craig TP, Cleland SJ.
    Amino Acids; 2011 Jul 14; 41(2):507-15. PubMed ID: 20963457
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
    Egan JM, Meneilly GS, Habener JF, Elahi D.
    J Clin Endocrinol Metab; 2002 Aug 14; 87(8):3768-73. PubMed ID: 12161508
    [Abstract] [Full Text] [Related]

  • 19. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
    Rocca AS, Brubaker PL.
    Endocrinology; 1999 Apr 14; 140(4):1687-94. PubMed ID: 10098504
    [Abstract] [Full Text] [Related]

  • 20. Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.
    D'Alessio DA, Vogel R, Prigeon R, Laschansky E, Koerker D, Eng J, Ensinck JW.
    J Clin Invest; 1996 Jan 01; 97(1):133-8. PubMed ID: 8550824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.